Allan Saul
Honorary Research Fellow/Honorary Professor Burnet Institute/University of Melbourne, Australia
VALIDATE Role: Scientific Advisory Board Member
Research Keywords: Shigella, Salmonella, Streptococcus pyogenes, Malaria, COVID-19, Vaccine Development, Vaccine Trials, Epidemiology, Disease Modelling Biography: Dr Saul has a PhD in Biochemistry from the University of Queensland and has more than 40 years working in vaccine development, especially for vaccines for high volume Developing World applications. These include vaccines to prevent diseases caused by Plasmodium falciparum and P. vivax, Salmonella (Typhi, Paratyphi A and invasive nontyphoidal Salmonella), Shigella, Group A Streptococcus. He brings a unique perspective to vaccine development spanning Academia, NIH, developing country vaccine manufacturers and big Pharma. He retired in December 2019 and is now on the scientific advisory boards of multiple vaccine projects and Funding organizations. Dr Saul is an Honorary Senior Principal Research Fellow at the Burnet Institute and an Honorary Professor in the Department of Microbiology and Immunology at the University of Melbourne. He has published over 290 peer-reviewed papers and is an inventor on 18 families of granted patents.
Related Websites:
Key Publications: |
